Flu vaccine efficacy reduced because of H3N2 mutation during vaccine production

Health Headlines Commentary for December 4, 2017

Source:

Flu shot may bring only some protection this year: disease expert

Reference:

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

Bitnami